YSB (HKSE:09885) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:09885 YSB Inc HKSE:09885
74 GF Score
Price HK$3.55
GF Value HK$7.39
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is YSB FFO?

FFO (Funds from operations) only applies to REITs.

HKSE:09885
74GF Score
YSB Inc HKSE:09885
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is YSB (HKSE:09885) Overvalued in 2026?

Based on GuruFocus' analysis, YSB stock appears to be undervalued. The current stock price of HK$3.55 is trading 52% below its estimated GF Value™ of HK$7.39. GuruFocus considers YSB to be Significantly Undervalued.

Key valuation signals for HKSE:09885:

  • FFO:
  • GF Value™: HK$7.39 vs. price of HK$3.55 (52% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the HKSE:09885 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


YSB Business Description

Other Exchanges B1S:Germany
Address No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN, 510310
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The group is engaged in the wholesale and retail of pharmaceutical and healthcare products through offline channels, retail shops, and its online platform. It also operates an online marketplace that enables pharmaceutical distributors and vendors to sell pharmaceutical and healthcare products through the Group's platform. In addition, the Group provides SaaS solutions to downstream pharmacies and primary healthcare institutions to streamline inventory and patient management, and offers system technologies and operational support services through smart healthcare systems, integrated point-of-care testing and monitoring devices, digital management systems, and smart AI doctor-aid systems.
74GF Score

Get the complete analysis for HKSE:09885

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$3.55
Price
HK$7.39
GF Value